Bioengineered Antimicrobials To Assist Cystic Fibrosis Patients
By better understanding how antimicrobials bind and thereby get inactivated in the mucus of air passages, researchers at the University of Illinois may have found a way to help cystic fibrosis patients fight off deadly infections.”While not a cure, this work has potential as a therapeutic strategy against bacterial infections in cystic fibrosis,” said Gerard Wong a professor of materials science and engineering, of physics, and of bioengineering at the U. of I.
